IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,297,507 | +44.0% | 7,977,474 | +122.8% | 0.02% | +50.0% |
| Q2 2023 | $25,207,903 | +120795.4% | 3,580,668 | +4.9% | 0.01% | 0.0% |
| Q1 2023 | $20,851 | +175.7% | 3,412,599 | +188.3% | 0.01% | +200.0% |
| Q4 2022 | $7,563 | -99.9% | 1,183,539 | -3.1% | 0.00% | -42.9% |
| Q3 2022 | $11,697,000 | -48.0% | 1,220,965 | -40.0% | 0.01% | -50.0% |
| Q2 2022 | $22,479,000 | -45.6% | 2,036,087 | -17.9% | 0.01% | -36.4% |
| Q1 2022 | $41,301,000 | +555.1% | 2,480,507 | +651.0% | 0.02% | +633.3% |
| Q4 2021 | $6,305,000 | +1112.5% | 330,291 | +1551.5% | 0.00% | – |
| Q2 2021 | $520,000 | -97.8% | 20,000 | -97.3% | 0.00% | -100.0% |
| Q1 2021 | $23,143,000 | +86.5% | 730,977 | +173.3% | 0.02% | +77.8% |
| Q4 2020 | $12,409,000 | -59.1% | 267,428 | -71.0% | 0.01% | -75.7% |
| Q3 2020 | $30,340,000 | +88.1% | 921,645 | +56.9% | 0.04% | +68.2% |
| Q2 2020 | $16,127,000 | +220.8% | 587,509 | +249.9% | 0.02% | +83.3% |
| Q1 2020 | $5,027,000 | -1.5% | 167,930 | -8.9% | 0.01% | +100.0% |
| Q4 2019 | $5,104,000 | -31.0% | 184,400 | -54.6% | 0.01% | -50.0% |
| Q3 2019 | $7,398,000 | +116.3% | 406,526 | +191.4% | 0.01% | +140.0% |
| Q2 2019 | $3,421,000 | +1854.9% | 139,500 | +657.9% | 0.01% | – |
| Q1 2019 | $175,000 | -74.2% | 18,407 | -69.5% | 0.00% | -100.0% |
| Q3 2018 | $679,000 | -92.6% | 60,387 | -91.5% | 0.00% | -91.7% |
| Q2 2018 | $9,125,000 | +5.8% | 712,922 | +39.7% | 0.01% | 0.0% |
| Q1 2018 | $8,625,000 | +66.0% | 510,364 | -21.4% | 0.01% | +71.4% |
| Q4 2017 | $5,197,000 | -67.8% | 649,651 | -68.8% | 0.01% | -72.0% |
| Q3 2017 | $16,131,000 | +411.1% | 2,081,480 | +384.7% | 0.02% | +316.7% |
| Q2 2017 | $3,156,000 | – | 429,435 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |